Myfortic 360 mg/1

Myfortic 360 mg is a delayed-release tablet containing mycophenolic acid, used to prevent organ rejection post-transplant. This immunosuppressant is commonly prescribed for kidney transplant patients.

Myfortic 360 mg is primarily used to prevent rejection in kidney transplant patients. It works by suppressing the immune system to help the body accept the new organ. This medication is often part of a broader treatment plan that includes other immunosuppressants and careful monitoring by a healthcare provider.

Common effects of Myfortic 360 mg may include gastrointestinal issues such as diarrhea, nausea, or vomiting. Some users also report fatigue or an increased risk of infections due to the immunosuppressant nature of the drug. Always consult a healthcare professional for personalized advice.

Myfortic 360 mg should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause birth defects. Regular blood tests are often recommended to monitor kidney function and blood cell counts. Store the medication as directed and keep it out of reach of children.

Myfortic 360 mg may interact with other medications, including antacids containing magnesium or aluminum, which can reduce its effectiveness. It is also important to avoid taking it with cholestyramine, as this can significantly decrease the absorption of mycophenolic acid. Always inform your healthcare provider about all medications you are taking.